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Abstract A major acute phase protein (pig-MAP) has been iso-
lated from the sera of pigs after turpentine injection. The protein 
is the pig counterpart of a recently cloned human serum protein 
denominated PK-120, which is a putative substrate for kallikrein 
[Nishimura et aI., 1995 FEBS Lett. 357, 207-211[. The protein 
exists in other mammalian species and it is also an acute phase 
protein, at least in the rat. Pig-MAP shows homology, as PK-120, 
with the heavy chain 2 (HC-2) of the inter-a-trypsin inhibitor 
superfamily but does not possess trypsin inhibitory activity. 
Key words: Pig plasma protein; Acute phase response (pig. rat); 
Human PK-120; Inter-a-trypsin inhibitor 
1. Introduction 
Acute inflammation induces an important increase in the 
concentration of a subset of plasma proteins called acute phase 
reactants [1,2]. These proteins have been particularly well stud-
ied in man and rat. Though the roster of these proteins is 
probably not complete, in humans the concentrations of C 
reactive protein (CRP) and serum amyloid A increase more 
than a hundred times during the acute phase response. The 
plasma concentration of ai-acid glycoprotein (AGP), hapto-
globin, ai-antitrypsin and fibrinogen can also increase several 
times after the onset of this process. In the rat, a type of 
a 2-macroglobulin. AGP, haptoglobin, fibrinogen and, particu-
larly, a cysteine proteinase inhibitor, which is a kininogen. are 
the major acute phase proteins [3]. In other species the acute 
phase protein response is poorly defined [4]. 
In a recent work we have characterized the acute phase 
proteins in pigs after turpentine injection [5]. Besides CRP and 
haptoglobin we have observed a serum a 2-g10bulin. with an Mr 
about 115-120 kDa. which apparently is the major acute phase 
(MAP) protein in pigs, This protein. called pig-MAP. seemed 
to be a new mammalian plasma protein. 
The present work describes the isolation of pig-MAP. Anti-
bodies against pig-MAP. raised in rabbits, allow us to detect 
proteins analogous to it in other species, including rat and man. 
In the rat this protein is also an important acute phase reactant. 
Partial amino acid sequence of the pig protein reveals homol-
ogy with the heavy chain 2 (HC-2) of the inter-a-trypsin inhib-
itor (ITI) family of serum proteins. A sample of the human 
counterpart has also been sequenced in its amino terminal re-
gion. Both human and pig proteins show a high homology. 
Recently. Nishimura et al. [6] have reported the cDNA cloning 
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and the deduced amino acid sequence of a new human plasma 
protein denominated PK-120, which is a putative kallikrein 
substrate [6.7]. This human protein and pig-MAP are homolo-
gous. 
2. Materials and methods 
2.1 Materials 
Acute phase response was mduced m pigs by turpentme injection [5] 
or surgically after small bowel autotransplantatIOn (Experimental 
TransplantatIOn Programme of the Medicine Faculty, Zaragoza Uni-
versity). Blood samples were obtained Just before the mflammatory 
treatment and dally afterwards [5]. Acute mflammatlOn was also in-
duced m Wistar rats by turpentine injection [3] and blood samples were 
obtained 48 h later. As a controL age and sex mated rats were used. 
Human plasma from healthy donors was provided by the UniverSity 
Hospital. 
:: 2. Pig-MAP isolatlOll 
Pig-MAP was isolated from 48 h acute phase pig serum contammg 
the followmg protease inhibitors: 60 mM EDTA. I mM phenylmeth-
ylsulphonyl fluonde. 3 mg/ml Polybrene (hexadlmetrine bromide), and 
10 mM Iysme-HCI Aliquots of serum (total, 10 ml) were first chroma-
tographied on a 100 x 2 cm Sephadex G-150 column eqUilibrated m 
0.15 M NaCL 0 01 M phosphate buffer. pH 7 4 contammg 0.1 % NaN,. 
Fractions enriched m pig-MAP contammg low amounts of albumm 
were selected. The fractIOns were then dialysed against 0.05 M Tns-
HCL 0.02 M NaCi pH 7.5 buffer (Tns buffer) and applied to a 10 x 2 
cm column of Sepharose 4B-immobllized Clbacron Blue [8] and eqUil-
Ibrated m the same butTer. A fractIOn. which con tamed pig-MAP and 
albumm as the major contammant. was eluted with the Tns buffer 
contaming up to 0.5 M NaCI. Fmall). thiS fractIOn was dlalysed agamst 
the Tns buffer and apphed to a 10 x 2 cm DEAE-Sephadex A-50 
column eqUilibrated m the same buffer Proteins were eluted with a 
saline linear gradient up to 03 M NaCI m the TrIS buffer (total \olume 
500 ml). In each step. fractions contailllng pIg-MAP were mOllltored 
by SDS-PAGE (10%) under reductive condltlom, 
2.3 PUI'l{icallOn of Ihe hUlIlan protein homologous 10 pig-,HAP 
A partIal purificatIOn of the human serum protem homologous to 
pig-MAP was carried out as follows' a protem fraction was obtamed 
by 40-60% saturatIOn ammOlllum sulphate preCIpitatIOn of 400 ml fresh 
human serum contammg protease inhIbitors (sectIOn 2.2). ThiS fractIOn 
was the startmg sample for further pUrIfication of the protem usmg a 
SImilar method to that descnbed for pig-MAP. 
:: 4 AnliserulIl and anllbodzes 
Antiserum to pig-MAP was raised in rabbits by subcutaneous mJec-
tlOns of purified pig-MAP as preVIOusly reported for other pig serum 
proteins [9]. The antiserum was adsorbed With msolubilized normal pig 
plasma [10] previously selected by the very low concentratIOn of pig-
MAP. AntIbodies agamst the protein were Isolated uSlllg insolubilized 
acute phase pig serum [10] as the Immunoadsorbent 
:: 5 Electrophoresis and Western blottlllg 
Protein samples were analysed by reductIve SDS-PAGE (10%). The 
separated protems were electroblotted from the gel to llltrocellulose 
membranes (Hybond-C ;,uper. Amersham) at 20 V. for 1 h m a semi-dry 
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Fig.!. Reductive SDS-PAGE (10%) of samples obtained during pig-
MAP purification. Lane L starting acute phase pig serum; lane 2. 
fraction after Sephadex G-150; lane 3. pig-MAP fractIOn eluted from 
Sepharose 4B-immobilized Cibacron Blue; lane 4, purified pig-MAP 
after DEAE-Sephadex A-50 chromatography; lane 5, molecular weight 
markers. 
transfer cell (BIO-RAD). After blotting. the membranes were mcubated 
first with isolated antibodies to pig-MAP (I ,ug/ml) and then with 
alkaline phosphatase-conjugated goat anti rabbit IgG, absorbed with 
human serum protems (Sigma. diluted 1110,000). The Immunocom-
plexes were revealed with a fresh solutIOn of 0.1 mg/ml Nitro-blue 
tetrazolium chlonde and 0.06 mg/ml 5-bromo-4-chloro-3-indolyl phos-
phate in 0.2 M Tris. 1 mM MgCI, pH 9.6 buffer The MW-SDS-200 
protein kit (Sigma) was used for the molecular weight markers. 
2 6. Trypsin digestion and sequenclIlg 
Pig-MAP (500 ,ug) was digested with 1/50 amount (by weight) of 
sequencing grade trypsm (Boehnnger-Mannhelm) in a 0 1 M 
NH4HCO j • pH 8.3 buffer for 6 h at 37°C (total volume 700 ,ul). The 
native protem (100 ,ug) and the tryptic digestion sample were electro-
phoresed m reductive SDS-PAGE (8 to 20% gradient) electro blotted as 
before to polyvinilidene difiuonde membranes (Immobllon p. MII-
hpore) and stamed with Coomassle bnlliant blue-R [II]. Bands corre-
spondmg to the undigested protein and to a 23 kDa fragment were cut 
out and directly applied for NH,-termmal ammo aCid sequentlation. 
ThiS was carned out by custom charge m the Institute of Animal 
Physiology and Genetics Research. Babraham. Cambridge. UK. The 
purified human protem was treated in a similar way. 
2.7 Determination of pig-MAP 
Serum concentration of pig-MAP was determmed by radial immu-
nodiffusion in 1% agarose gels contammg the speCific rabbit antiserum 
against the protein. Punfied pig-MAP was used as a reference standard. 
2. S. Protease inlubltlOn 
Trypsin and chymotrypsin inhibitors were detected by the method of 
Uriel and Berges [12] in gels after conventional or SDS-PAGE electro-
phoresis. 
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Fig. 3 Western blotting of 1 ,ul of 1/5 diluted sera from: a pig before 
(lane 1) and 48 h after turpentine injectIOn (lane 2); a pig before (lane 
4) and 48 h after small bowel autotransplantation (lane 3). 
3. Results 
Fig. I shows the protein patterns in reductive SDS-PAGE of 
samples collected at different steps in the pig-MAP purification. 
The purified protem fraction shows a major band of around 120 
kDa (lane 4). Minor bands of around 80 and 50 kDa are 
fragments of the protein since they react with specific antibod-
ies to pig-MAP by Western blotting. Using the specific antisera, 
the concentration of pig-MAP was determined in the sera of 
five pigs with turpentine-induced inflammation (Fig. 2a). A 
maximum in the concentration of pig-MAP was observed 24-
48 h after turpentine injection. This concentration reaches val-
ues of 4-8 mg/ml, which are 10 to 30 times higher than before 
the inflammatory process. To confirm that the rise of pig-MAP 
is not the consequence of a toxic effect of turpentine, the pro-
tein was also determined in sera of pigs under small bowel auto-
transplantation (surgical trauma). The results (Fig. 2b) were 
similar to those obtained before. Western blotting analysis indi-
cates that the intensity of the 120 kDa band dramatically in-
creases in sera of inflammated pigs (Fig. 3). This 120 kDa 
polypeptide correspond to the Mr of the native protein as con-
firmed by gel filtration on a calibrated Sephadex G-150 column. 
Proteins homologous to pig-MAP were detected in the sera 
of other animal species (sheep. bovine, human and rat) by 
Western blotting and revealed with anti pig-MAP antibodies 
(Fig. 4). In all these cases. a band of around 120 kDa was 
observed. Lanes 4 and 5 in Fig. 4 correspond to pooled sera 
from control and turpentine injected rats. The intensity of the 
120 kDa band greatly mcreases in the sera of in flam mated rats. 
Therefore. in the rat the homologous protein to pig-MAP is 
also an acute phase protein. 
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Fig. 2. Time-course of pig-MAP serum concentration (mg/ml) in pigs with acute phase processes: (a). values from five pigs. before (day 0) and on 
subsequent days after turpentine injectIOn. In two pigs (closed circles and closed squares) only the samples corresponding to 0 and 2 days were 
analysed; (b) values from three pigs before (day 0) and on subsequent days after small bowel autotransplantatIOn. 
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NH2-terminal amino acid sequences from pig-MAP, from the 
23 kDa tryptic fragment and from the homologous human 
protein, are shown in Fig. 5. Search in the SWISS-PROT Pro-
tein Database showed moderate homology with the HC-2 of the 
IT! [13]. However, the pig-MAP did not possess trypsin or 
chymotrypsin inhibitory activity detectable by the method of 
Uriel and Berges [12], which, by contrast, easily detects inhib-
itory activity of IT! components (data not shown). Recently, 
Nishimura et al. [6] have published the cDNA cloning of a new 
human serum protein denominated PK-120. The deduced 
amino acid sequence of this protein shows a high homology 
with the partial sequences of the pig-MAP and identity with the 
NH2-terminal sequence of the human protein reported here 
(Fig. 5). Therefore, pig-MAP is homologous to human PK-120. 
4. Discussion 
In a recent work [5] we have detected a major acute phase 
serum protein in pigs, which has not been previously described 
in this or in other species. The protein has been now isolated 
to homogeneity. Antibodies to it allow us to detect homologous 
proteins to it in several mammalian species. including man and 
the rat. In the latter the protein is also a major acute phase 
component. since the concentration of the protein increases 
several times 48 h after turpentine injection (Fig. 4). This fact 
is surprising because the rat has been widely used as a model 
in studies of acute inflammation. Probably, the human protein 
homologous to pig-MAP is also an acute phase reactant. Pre-
liminary ~tudies from our laboratory indicate that the intensity 
of the 120 kDa band sigmficantly increases in the sera of 60% 
of patients after different surgical trauma. However. more sys-
tematic studies need to be performed to confirm that this 
human protein is also an acute phase protem. 
The NH,-terminal amino acid sequences from pig-MAP and 
from an internal tryptic fragment show a high homology (more 
than 85%) with the corresponding regIOns of a newly described 
human serum protein. denominated PK-120. which is a puta-
tive substrate for kallikrein [6]. This human protein was previ-
ously isolated from human plasma [7,14] and shows a notable 
susceptibility to proteolysIs. We have observed the same effect 
during the isolation of the pig-MAP (see Fig. I). Moreover. 
degradation products of this protein increase in serum samples 
stored for a few days at 4° C. 
PK-120 and pig-MAP show homology with the ITI superfa-
mily of serum trypsin inhibitors [6. this work]. These inhibitors 
are constituted by one or two heavy chams and one light chain 
denominated bikunin [15]. Heavy and light chains are bound 
together by glycosamino glycan bridges that are resistant to the 
action of reductive SDS buffers [16]. The glycosammo glycans 
can be broken down by hyaluronidase or chondroitinase 
[16.17]. Blkunin is formed by two Kunitz type domains that are 
1 2 3 4 5 
Fig. 4. Western blottmg usmg specific antibodies anti pig-MAP of I ,ul 
of serum from the following 5pecies' sheep (lane I): bovine (lane 2); 
human (lane 3). normal (lane 4) and turpentme mJected (lane 5) rats. 
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Fig. 5. Ammo acid alignments of the NH,-termmal sequences of: (top). 
pig-MAP and human homologous protein (h-MAPH) compared With 
the sequence (amino acids 12--38) from ITI-HC2 [13] and NH,-terminal 
sequence from human PK-120 [6]; (bottom), a 23 kDa tryptic fragment 
of pig-MAP compared With the corresponding sequences of the lTI-
HC2 (ammo aCids 206--224) and human PK-120 (ammo aCids 190--214) 
I. mdicates ammo aCid Identity and •. analogy. 
responsible for the trypsin-like protemase inhibition [15]. This 
bikunin chain seems to be absent in pig-MAP because this 
protein does not inhibit trypsin. 
Proteins of the IT! superfamily, besides their trypsin mhib-
itory activity. interact with components of extracellular matrix 
[18-22]. This property may be conSidered as a modulatory 
factor in cell migration and proliferation. The fact that kal-
likrein acting upon PK -120 could release pep tides with kinin 
activity [6] and the fact that thiS protein is an acute phase 
protein. open a new gate to study such a complex process as 
inflammation. 
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